狼疮性肾炎
医学
免疫学
系统性红斑狼疮
免疫系统
红斑狼疮
肾炎
疾病
内科学
抗体
作者
Eleni Papachristodoulou,Vasileios C. Kyttaris
标识
DOI:10.1016/j.clim.2024.110200
摘要
Systemic Lupus Erythematosus (SLE) and lupus nephritis treatment is still based on non-specific immune suppression despite the first biological therapy for the disease having been approved more than a decade ago. Intense basic and translational research has uncovered a multitude of pathways that are actively being evaluated as treatment targets in SLE and lupus nephritis, with two new medications receiving FDA approval in the last 3 years. Herein we provide an overview of targeted therapies for SLE including medications targeting the B lymphocyte compartment, intracellular signaling, co-stimulation, and finally the interferons and other cytokines.
科研通智能强力驱动
Strongly Powered by AbleSci AI